| Date Filed | Type | Description |
| 09/26/2023 |
4
| Napolitano Richard J (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Teladoc Health, Inc.|
Txns:
| Sold 219 shares
@ $18.679, valued at
$4.1k
Exercised 601 restricted stock units
@ $0 |
|
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
4
| Waters Michael Willem (COO) has filed a Form 4 on Teladoc Health, Inc.|
Txns:
| Sold 19,340 shares
@ $27.029, valued at
$522.7k
Exercised 45,277 restricted stock units
@ $0 |
|
| 08/03/2023 |
4
| Raman-Tangella Vidya (CHIEF MEDICAL OFFICER) has filed a Form 4 on Teladoc Health, Inc.|
Txns:
| Sold 5,215 shares
@ $27.029, valued at
$141k
Exercised 10,244 restricted stock units
@ $0 |
|
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 07/28/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/27/2023 |
4
| Jensen Claus Torp (CHIEF INNOVATION OFFICER) has filed a Form 4 on Teladoc Health, Inc.|
Txns:
| Sold 6,547 shares
@ $29, valued at
$189.9k
|
|
| 07/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/25/2023 |
8-K
| Quarterly results |
| 07/19/2023 |
4
| Jensen Claus Torp (CHIEF INNOVATION OFFICER) has filed a Form 4 on Teladoc Health, Inc.|
Txns:
| Sold 6,547 shares
@ $27, valued at
$176.8k
|
|
| 07/18/2023 |
4
| Trencher Daniel (CHIEF STRATEGY OFFICER) has filed a Form 4 on Teladoc Health, Inc.|
Txns:
| Sold 1,000 shares
@ $24.66, valued at
$24.7k
|
|
| 07/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/10/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 10.6% stake in Teladoc Health Inc. |
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/30/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/30/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/30/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/30/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
|